Presentation TVT 2019 Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease? Presenter: Vinod Thourani June 13, 2019
Presentation TVT 2019 Disparities in the Treatment of Aortic Stenosis: Race, Gender, and Referring Physician Biases Presenter: J. Matthew Brennan June 13, 2019
Presentation TVT 2019 Status Update on Transcatheter TR Therapies Presenter: Maurizio Taramasso June 13, 2019
Presentation TVT 2019 Tricuspid Valve Imaging: Challenges, Conundrums, and Solutions Presenter: Rebecca Hahn June 13, 2019
Presentation TVT 2019 Does the Natural History of TR Justify Earlier Treatment? Presenter: Jeroen Bax June 13, 2019
Presentation TVT 2019 Does a Multi-Device Lesion-Specific Approach Make Sense (Including Sequential Therapies)? Presenter: Felix Kreidel June 13, 2019
Presentation TVT 2019 Reactions From the Surgical Community Presenter: Patrick McCarthy June 13, 2019
Presentation TVT 2019 Reactions From the Cardiology Community Presenter: Blase Carabello June 13, 2019
Presentation TVT 2019 Highlights From the CoreValve Low-Risk Trial Presenter: Jeffrey Popma June 13, 2019
Presentation TVT 2019 Highlights From the PARTNER 3 Low-Risk Trial Presenter: Michael Mack June 13, 2019
Presentation TVT 2019 Reactions From the Cardiology Community Presenter: Allan Schwartz June 13, 2019
Presentation TVT 2019 Proportionate and Disproportionate FMR: A New Conceptual Framework to Explain Differences in Clinical Trial Outcomes Presenter: Paul Grayburn June 13, 2019
Presentation TVT 2019 A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications Presenter: Gregg Stone June 13, 2019
News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019